New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
05:59 EDTBLUEbluebird bio announces data from HGB-205 clinical study
bluebird bio on Saturday released initial clinical data from its HGB-205 clinical study of its LentiGlobin BB305 product candidate in beta-thalassemia major subjects. The company said the clinical update provided on two subjects treated in the prior LG001 Study using the prior lentiviral HPV569 product candidate; Subject 3 remains blood transfusion independent 72 months after being transplanted with the lentiviral HPV569 product candidate; Subjects 3 and 4 are producing 2.7 g/dL and 0.4 g/dL of therapeutic beta A-T87Q-globin post-transplant, respectively; No drug product related adverse events were reported in the LG001 Study. The company sees reporting additional data from the HGB-205 Study and from our ongoing Northstar Study in late 2014.
News For BLUE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 17, 2014
11:49 EDTBLUEPiper Jaffray healthcare analysts to hold an analyst/industry conference call
Subscribe for More Information
07:16 EDTBLUEMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 13, 2014
07:30 EDTBLUECredit Suisse to hold a conference
Healthcare Conference is being held in Scottsdale, Arizona on November 10-13 with webcasted company presentations to begin on November 13 at 11 am; not all company presentations may be webcasted. Webcast Link
November 12, 2014
07:08 EDTBLUEbluebird bio reports Q3 EPS (61c), consensus (50c)
Reports Q3 revenue $6.37M, consensus $6.21M.
November 10, 2014
07:08 EDTBLUEbluebird bio names James DeTore as CFO, treasurer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use